Rocket


Overview
Financials
News + Filings





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Curative Biotechnology Inc

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20
   S-1/AS-1/A
Revenues  6.14.8
            Revenue growth  27.0% 
Cost of goods sold  1.00.1
Gross profit  5.14.7
            Gross margin  83.4%97.0%
Selling, general and administrative   [+]4.24.6
Research and development  0.8 
Other operating expenses  5.14.7
EBITDA   [+]-5.0-4.6
            EBITDA margin  -81.7%-95.5%
Depreciation and amortization  0.00.0
EBIT   [+]-5.0-4.6
            EBIT margin  -81.8%-95.6%
Non-recurring items   [+]0.00.0
Interest expense  0.20.0
Other income (expense), net   [+]-0.1 
Pre-tax income  -5.3-4.7
Income taxes  0.00.0
            Tax rate  0.0%0.0%
Net income  -18.8-4.7
            Net margin  -307.9%-97.1%
   
Basic EPS   [+]($15.02)($5.72)
Diluted EPS   [+]($15.02)($5.72)
   
Shares outstanding (basic)   [+]1.30.8
Shares outstanding (diluted)   [+]1.30.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy